ACC: COVID-19 Vaccination Cuts Risk for Cardiac Events With SARS-CoV-2 Infection
Findings significant for both partial and complete COVID-19 vaccination
Findings significant for both partial and complete COVID-19 vaccination
For adults with 2 or more chronic conditions, booster dose of BNT162b2 or CoronaVac linked to reduction in mortality
Gout patients are susceptible to breakthrough COVID-19 infection and severe outcomes despite vaccination.
Risk for severe outcomes of COVID-19 higher for patients with hematologic versus solid cancer
In addition to worsening asthma, other respiratory disorders, and heart conditions, exposure to wildfire smoke can also compromise immunity in healthy individuals.
People with Medicare or Medicaid and those with private health insurance would likely get the vaccine for free
Researchers evaluated patients with documented care for long COVID to determine factors associated with its occurrence.
Vaccination decreased the risk for COVID-related hospitalization and death, according to a retrospective study.
The aim of the study was to evaluate the occurrence of SLE flares after COVID-19 vaccination.
Future booster updates would likely target whatever omicron subvariant is spreading